Abstract
Three generations of iodinized contrast media (CM) are available for use in visualization of X-ray procedures. The three types of CM are all primarily based on a tri-iodinated benzene ring structure but differ in the structure of the attached side chains. First-generation CM have an ionizing carboxyl group, meaning they dissociate into two particles in solution. Consequently, these CM have a high osmolality that has been found to result in toxic effects such as pain and heat sensation on injection and a significant risk of CM-induced nephropathy (CIN)—an important adverse event associated with CM use. Low-osmolar CM (LOCM) were developed to overcome these toxic effects and are indeed better tolerated than high-osmolar CM (HOCM). In particular, LOCM have been shown to carry a lower risk of CIN, especially in high-risk patients. However, renal failure is still one of the most severe reported adverse events associated with LOCM. Therefore, a third generation of CM has been developed that is iso-osmolar with plasma offering potential benefits with regards to tolerability compared to LOCM. Two studies in high-risk patients have shown that iodixanol is associated with a lesser effect on renal function than the LOCM iohexol. Thus, clinical data have shown that an iso-osmolar CM should be considered in patients at high risk for CIN undergoing CM-enhanced procedures.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aspelin, P. Why choice of contrast medium matters. Eur Radiol Suppl 16 (Suppl 4), D22–D27 (2006). https://doi.org/10.1007/s10406-006-0183-4
Issue Date:
DOI: https://doi.org/10.1007/s10406-006-0183-4